Rapid Risk Assessment: Extensively drug-resistant (XDR) Neisseria gonorrhoeae in the United Kingdom and Australia
Figure 5. Rate of reported confirmed gonorrhoea cases per 100 000 population, EU/EEA countries reporting consistently, 2005−2014
Table 1: Number and rate of reported confirmed gonorrhoea cases per 100 000 population, EU/EEA, 2010–2014
Figure 4. Percentage of gonorrhoea infections by transmission category and gender (n=56 695), EU/EEA, 2014
The surveillance of gonococcal antimicrobial susceptibility surveillance in Europe is essential for detecting emerging and increasing antimicrobial resistance and making quality-assured data available to inform revisions of treatment guidelines.
Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA
WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014
Is the tide turning again for cephalosporin resistance in Neisseria gonorrhoeae in Europe? Results from the 2013 European surveillance